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Background: Cefprozil, an antibiotic used to treat bacterial infections, was labeled with 99mTc. 99mTc-cefprozil was
prepared by adding 99mTc to cefprozil in the presence of 50 µg SnCl2.dihydrite at pH 4 and 30-minutes reaction time.
The radiochemical yield and purity of 99mTc-cefprozil were evaluated after species separation individually followed by
subsequent quantification of the free and complexed species.
Methods: 4 mg of cefprozil was accurately weighed and transferred to an evacuated penicillin vial. Exactly 50 µg SnCl2
solution was added and the pH of the mixture was adjusted to 4 using 0.1N HCl, then the volume of the mixture was
adjusted to one ml with N2-purged bidistilled water. One ml of freshly eluted
99mTcO4- (200- 400MBq) was added to
the above mixture.
Results: The obtained maximum radiochemical yield was found to be 97.5% ± 0.8%. The 99mTc-cefprozil complex was
stable for 6 hrs. The biological distribution of 99mTc-cefprozil was experimentally investigated in induced-infection mice,
in the left thigh, using Staphylococcus aureus.
Conclusions: T/NT for 99mTc-cefprozil was found to be 5.5±0.12 at 2 hrs after intravenous injection, which was higher
than that of the commercially available 99mTc-ciprofloxacin followed by gradual decline. The abscess to normal muscle
ratio indicated that 99mTc-cefprozil could be used for infection imaging. Moreover, 99mTc-cefprozil could efficiently
differentiate between bacterial infection and sterile inflammation.
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Nuclear medicine scintigraphy (NMS) techniques are
proving valuable in understanding the disease processes
at molecular levels without the inconvenient invasive
procedures, if a specific ligand is provided for a
pathological process. The role of NMS in the diagnosis
of infection and its discrimination from non-infective
inflammatory processes and tumors at an early stage
is clinically vital for appropriate management (Wouter et al.
2010; Sandip et al. 2009; David-Axel et al. 2006;
Carrino et al. 2006). The radiolabeled leucocytes can be
considered as gold standard for the identification of
inflammatory foci in the intestine and bone tissues
(Weiner 1990). The development of new radiophar-
maceuticals that do not require the manipulation of
blood and are able to differentiate between inflammatory* Correspondence: msanad74@yahoo.com
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in any medium, provided the original work is pand infectious processes with high sensibility and specificity
is considered as the object of recent research. Therefore,
other preparations such as 99mTc-nanocolloid, 67Ga-citrate,
and 99mTc or 111In-labeled human polyclonal immuno-
globulin are currently being tested (Buscombe et al. 1991).
However, none of the preparations is capable of distinguish-
ing between infections and inflammatory lesions in a clinic-
ally useful manner. Recently, a new proposal is based on
the use of radiolabeled antibiotics. One of the most import-
ant radiopharmaceuticals which are now currently available
for imaging infection, the antimicrobial agent ciprofloxacin
labeled with 99mTc, has probably shown significant
benefits. The fundamental problems of 99mTc-ciprofloxa-
cin preparation discussed in the literature (Mcafee et al.
1991; (Akhtar et al. 2005, 2004; Nibbering et al. 2004;
El-Ghany et al. 2007) are related to radiochemical
purity as well as to the stability of the labeled com-
plex. So, other antimicrobial agents such as levofloxacin
(El-Ghany et al. 2005), pefloxacin (Motaleb 2007a, b),s is an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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2007a, b), cefuroxime (Yurt Lambrecht et al. 2008), rifam-
picin (Syed et al. 2010), and amoxicillin (Motaleb and
Sanad 2012) were labeled with 99mTc to be used for
imaging sites of infection and to overcome the drawback
of 99mTc-ciprofloxacin (Kleisner et al. 2002; Yang et al.
2009). Cefprozil is a semi-synthetic broad-spectrum
cephalosporin antibiotic. Cefprozil is a cis and trans
isomeric mixture (≥90% cis). The chemical name of cefpro-
zil is (6R,7R)-7-[(R)-2-amino-2-(p-hydroxyphenyl) aceta-
mido]-8-oxo-3-propenyl-5-thia-1-azabicyclo [4.2.0] oct-2-
ene-2-carboxylic acid (Petropoulos et al. 2009; Shaikh et al.
2008). Cefprozil has in vitro activity against a broad
range of gram-positive and gram-negative bacteria.
The bactericidal action of cefprozil results from inhibition
of cell wall synthesis (Breier et al. 2002; Can 2011). In this
paper, cefprozil was labeled with the most widely used
imaging radionuclide, 99mTc. Factors affecting the labeling
yield of 99mTc-cefprozil complex and biological distri-
bution in inflammation bearing animals were studied
in detail.Experimental
Chemicals and materials
Cefprozil was purchased from Sigma-Aldrich Chemical
Company (St. Louis, MO, USA); its structure is presented
in Figure 1. All the other chemicals were purchased from
Merck (Whitehouse Station, NJ, USA), and they were
reactive grade reagents. The water used is purged with
nitrogen gas to give deoxygenated bidistilled water.Apparatus
Well-type γ-scintillation counter: Scalar Ratemeter
SR7 (Nuclear Enterprises Ltd., USA); pH meter: model
601, a digital ion analyzer (Orion Research, Jacksonville,
FL, USA); ionization chamber: model CRC-15R (Capintec,
Ramsey, NJ, USA); precision electronic balance: model
HA 120 (MAD Company Ltd., Japan); stirring hot plate:
model 210T Thrmix (Fisher, Waltham, MA, USA);
electrophoresis apparatus: E.C. Corporation (Albany,
OR, USA)Figure 1 The chemical structure of cefprozil.Labeling of cefprozil
Cefprozil (4 mg) was accurately weighed and transferred
to an evacuated penicillin vial. Exactly 50-μg SnCl2 solu-
tion was added, and the pH of the mixture was adjusted
to 4 using 0.1 N HCl; then, the volume of the mixture
was adjusted to 1 ml with N2-purged bidistilled water.
One millimeter of freshly eluted 99mTcO4− (200 to
400 MBq) was added to the above mixture. The reaction
mixture was vigorously shaken and allowed to react at
room temperature for a sufficient time to complete the
reaction. This experiment was conducted to study the
different factors that affect the labeling yield such as tin
content (as SnCl2·2H2O), substrate content, pH of the
reaction medium, and reaction time. For labeling
process, trials were performed for each factor under
investigation to obtain the optimum value. The experi-
ment was repeated with all factors kept at optimum values
except the factor under study, until the overall optimal
conditions are achieved.Separation methods and recovery of 99mTc-cefprozil
complex
Paper chromatography
The radiochemical yield of 99mTc-cefprozil was determined
by paper chromatography, in which the reaction product
was spotted on ascending paper chromatography strips
(10 × 1.5 cm). Free 99mTcO4− in the preparation was
determined using acetone as the mobile phase. Reduced
hydrolyzed technetium was determined by using ethanol/
water/ammonium hydroxide mixture (2:5:1) or 5 N NaOH
as the mobile phase. After complete development, the
strips were dried, cut into 0.5-cm pieces, and counted in a
well-type γ-scintillation counter.Electrophoresis conditions
Electrophoresis was done with EC-3000 p-series prog-
rammable power and chamber supply units (E.C.
Apparatus Corporation) using cellulose acetate strips.
The strips were moistened with 0.05 M phosphate
buffer pH 7.2 ± 0.2 and then were introduced in the cham-
ber. The samples (5 μl) were applied at a distance of 10 cm
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at an applied voltage of 300 V and standing time of 1.5 h.
The developed strips were dried and cut into 1-cm
segments and counted by a well-type NaI scintillation
counter. The radiochemical yield was calculated as
the ratio of the radioactivity of the labeled product to
the total radioactivity
HPLC analysis
A simple, short, rapid, sensitive, and robust reversed
phase high-performance liquid chromatographic (HPLC)
method was developed and validated to measure the
amount of cefprozil in dissolution profile. An isocratic
elution of filtered sample was performed on cosmosil
RP18 LiChrosorb column (250 mm × 4 mm, 5 μm, Merck)
using water/acetonitrile solution (90:10, v/v) as mobile
phase and at a UV detection at 200 nm. The mobile phase
was delivered at a flow of 1.0 ml/min and at a main-
tained column temperature at 50°C, and quantification
was achieved with reference to the external standards
(Asikoglu et al. 2000). Then, fractions of 1.0 ml were
collected separately using a fraction collector up to 15 ml
and counted in a well-type γ-scintillation counter.
Stability of 99mTc-cefprozil in human serum
The stability of 99mTc-cefprozil was studied in vitro
by mixing 1.8 ml of normal human serum and 0.2 ml
of 99mTc-cefprozil and incubated at 37°C for 24 h. Exactly
0.2-ml aliquots were withdrawn during the incubation at
different time intervals up to 24 h and subjected to paper
chromatography for the determination of the percentage
of 99mTc-cefprozil, reduced hydrolyzed technetium, and
free pertechnetate.
Induction of infectious foci
A single clinical isolation of Staphylococcus aureus
(Boyd 1986) from biological samples was used to pro-
duce focal infection. Individual colonies were diluted
in order to obtain turbid suspension. Groups of five
mice, weighing approximately 25 g each, were injected
with 200 μl of the above suspension in the left thigh
muscle. Twenty-four hours was required to get gross
swelling in the infected thighs.
Induction of non-infected inflammation
Sterile inflammation was induced by injecting 200 μl of
turpentine oil (Robbins 1984), which was sterilized by
autoclaving at 121°C for 20 min, intramuscularly in the
left lateral thigh muscle of the Albino mice. Two days
later, swelling appeared.
In vitro binding of 99mTc-cefprozil to bacteria
Binding of 99mTc-cefprozil to S. aureus bacteria was
assessed by the method described elsewhere (Welling et al.2000). Briefly, 0.1 ml of sodium phosphate buffer contain-
ing about 5 MBq of 99mTc-cefprozil was transferred to a
test tube. Exactly 0.8 ml of 50% (v/v) of 0.01 M acetic acid
in phosphate buffer containing approximately 1 × 108 vi-
able bacteria was added. The mixture was incubated for
1 h at 4°C and then centrifuged for 5 min at 2,000 rpm
at 4°C. Simultaneously, the incubation was performed
in the presence of an excess of unlabeled cefprozil
(10-, 50-, 100-fold). The supernatant was removed, and
the bacterial pellet was gently resuspended in 1.0 ml of
ice-cooled phosphate buffer and recentrifuged. The super-
natant was removed, and the radioactivity in the bacterial
pellet was determined by a γ-counter. The radioactivity
related to the bacteria was expressed in percentages of the
added 99mTc activity bound to viable bacteria in regard to
the total 99mTc activity.Animal studies
The study was approved by the animal ethics committee of
the Labeled Compound Department and was in accordance
with the guidelines set out by the Egyptian Atomic Energy
Authority. For the infection model, the animals, Swiss
Albino mice (25 to 30 g), were intravenously injected with
100 μl (100 to 150 MBq) of sterile 99mTc-cefprozil, adjusted
to physiological pH via the tail vein, and kept alive in
metabolic cage for different intervals of time under
normal conditions. For quantitative determination of organ
distribution, five mice were used for each experiment, and
the mice were sacrificed at different times post-injection.
Samples of fresh blood, bone, and muscles were collected
in pre-weighed vials and counted. The different organs
were removed, counted, and compared to a standard
solution of the labeled cefprozil. The average percent values
of the administrated dose/organ were calculated. The
blood, bone, and muscles were assumed to be 7%, 10%, and
40%, respectively, of the total body weight (Motaleb 2001).
Corrections were made for background radiation and
physical decay during experiment. Both target and
non-target thighs were dissected and counted. Differences
in the data were evaluated with Student t test. Results
for p using the two-tailed test were reported, and all the
results are given as mean ± SEM. The level of significance
was set at P < 0.05.Results and discussion
Separation characteristics
In case of ascending paper chromatographic method,
acetone was used as the developing solvent, free 99mTcO4−
moved with the solvent front (Rf = 1), while
99mTc-cefprozil
and reduced hydrolyzed technetium remained at the point
of spotting. In the case of ascending paper chromato-
graphic method, the mixture was used as the developing
solvent; reduced hydrolyzed technetium remains at the
















Figure 2 HPLC radiochromatogram of 99mTc-cefprozil complex.
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solvent front (Rf = 1). The radiochemical purity was deter-
mined by subtracting the sum of the percentage of re-
duced hydrolyzed technetium and free pertechnetate from
100%.
The paper electrophoresis pattern revealed that the
99mTc-cefprozil complex moved towards the anode, indi-
cating the anionic nature of this complex. Under similar
condition, 99mTcO4− moved considerably toward the
anode, suggesting that it has a completely ionized nega-
tive charge.
An HPLC chromatogram was presented in Figure 2
and showed two peaks, one at fraction no. 3.25, which
corresponds to 99mTcO4− , while the second peak was
collected at fraction no. 7.3 for 99mTc-cefprozil which






















Figure 3 Effect of cefprozil amount on the labeling yield of 99mTc-cef
pH 4, and 30-min reaction time; n = 3.Factors affecting the labeling yield
Effect of ligand concentration
As shown in Figure 3, relatively low labeling yield of
99mTc-cefprozil, 75.3% ± 0.4%, was obtained at low ligand
concentration (1 mg). This low labeling yields was attrib-
uted to the ligand concentrations being insufficient to form
the complex with all of the reduced technetium-99m, while
the percentage of the colloid was high 14.9%± 0.5%.
Increasing the ligand concentration led to higher labeling
yield, and the maximum yield (97.5% ± 0.8%) was achieved
at 4 mg. By increasing the ligand concentration over the
optimum values, the labeling yield remained stable.
Effect of SnCl2·2H2O amount
The effect of the amount of stannous chloride was summa-
rized in Figure 4. The data showed that the radiochemical6 7 8 9 10 11
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prozil complex. Conditions: 1 to 10 mg of cefprozil, 50 μg Sn (II),
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Figure 4 Effect of Sn (II) amount on the labeling yield of 99mTc-cefprozil complex. Conditions: 4 mg cefprozil, 25 to 200 μg Sn (II), pH 4,
and 30-min reaction time; n = 3.
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present in the reaction mixture. At 25 μg SnCl2·2H2O, the
labeling yield of 99mTc-cefprozil was 65.6% ± 0.71% due to
insufficient SnCl2·2H2O concentration to reduce all per-
technetate, so the percentage of 99mTcO4− was relatively
high (Guarna et al. 2001). The labeling yield was signifi-
cantly increased by increasing the amount of SnCl2·2H2O
from 25 to 200. At 50 μg (optimum content), the max-
imum labeling yield of 97.5% ± 0.8% was obtained. By in-
creasing the amount of SnCl2·2H2O above the optimum
concentration value, the labeling yield decreased gradually
due to the conversion of the excess SnCl2·2H2O to colloid
and reached to 55.4% ± 0.82% at 200 μg SnCl2·2H2O




















Figure 5 Effect of pH on the labeling yield of 99mTc-cefprozil complex
reaction time; n = 3.Effect of pH of the reaction mixture
As shown in Figure 5, at pH 1 the labeling yield of
99mTc-cefprozil complex was relatively low (50%). The
yield increased with increasing pH of the reaction
mixture, reaching the maximum labeling yield of
97.5% ± 0.8% at pH 4. By increasing the pH greater than 4,
the labeling yield decreased again to 62.8% at pH 6, at
which the colloid impurity percentage becomes high
(32.7% ± 0.3%) (Motaleb et al. 2012, 2011).
Effect of reaction time
Figure 6 shows the effect of incubation time on the
radiochemical purity of the 99mTc-cefprozil complex. At
1-min post labeling, the radiochemical purity reached to4 5 6
 % Labeled compound
 % Free 99mTc
 % Colloid
pH
. Conditions: 4 mg cefprozil, 50 μg Sn (II), pH 1 to 6, and 30-min
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Figure 6 Effect of reaction time on the labeling yield of 99mTc-cefprozil complex. Conditions: 4 mg cefprozil, 50 μg Sn (II), pH = 4, 1- to
120-min reaction time; n = 3.
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maximum value of 97.5% ± 0.8% at 30 min. The radio-
chemical purity remains stable for up to 2 h (Ibrahim and
Sanad 2013; Sanad and Ibrahim 2013).Stability test
As shown in Figure 7, the in vitro stability of 99mTc-cefprozil
was studied in order to determine the suitable time for
injection to avoid the formation of the undesired products
that result from the decomposition of the complex. These
undesired radioactive products might be accumulated in
non-target organs. The results of the stability test showed






















Figure 7 In vitro stability of 99mTc- cefprozil in normal serum at optimwhich resulted in a small release of radioactivity of
17.0% ± 0.3% (n = 3 experiments) from the 99mTc-cefprozil,
as determined by paper chromatography.In vitro binding studies
In vitro binding studies revealed that the binding of
99mTc-cefprozil to S. aureus bacteria was similar to
that of 99mTc-ciprofloxacin, where the binding of
99mTc-cefprozil was in the range from 42% to 73% (n = 5),
while the binding of 99mTc-ciprofloxacin was in the range
from 40% to 65% (n = 3). The varying amounts of cefprozil
added (10- to 100-fold) showed significant decrease in the
binding of 99mTc-cefprozil to living bacteria, indicating12 16 20 24
 % Labeled compound




Table 1 Biodistribution of 99mTc-cefprozil in Staphylococcus aureus and turpentine oil-inflamed mice at different time
intervals
Percentage of injected dose/organs at different time intervals (h)
Organs and
body fluids
Turpentine oil S. aureus
15 min 30 min 2 h 4 h 15 min 30 min 2 h 4 h
Inflamed muscle 0.90 ± 0.01 1.11 ± 0.02 1.20 ± 0.03 0.90 ± 0.02 0.95 ± 0.01 1.15 ± 0.01 1.21 ± 0.02 1.36 ± 0.01
Normal muscle 0.63 ± 0.02 0.37 ± 0.01 0.33 ± 0.01 0.45 ± 0.01 0.38 ± 0.01 0.26 ± 0.02 0.22 ± 0.01 0.37 ± 0.02
Blood 15.7 ± 0.21 9.8 ± 0.13 2.90 ± 0.21 1.50 ± 0.21 12.5 ± 0.13 8.64 ± 0.21 2.5 ± 0.12 1.1 ± 0.12
Kidneys 11.15 ± 0.63 20.55 ± 0.31 10.42 ± 0.12 9.45 ± 0.23 13.7 ± 0.14 17.9 ± 0.33 11.2 ± 0.14 8.25 ± 0.41
Liver 12 ± 0.11 10.22 ± 0.11 8.24 ± 0.11 5.75 ± 0.21 15.33 ± 0.11 11.42 ± 0.11 7.8 ± 0.11 6.9 ± 0.11
Spleen 5.1 ± 0.11 3.0 ± 0.11 2.7 ± 0.12 1.9 ± 0.21 4.4 ± 0.21 3.8 ± 0.12 3.1 ± 0.21 2.5 ± 0.13
Intestine 8.72 ± 0.11 6.12 ± 0.11 5.26 ± 0.13 3.31 ± 0.21 5.37 ± 0.12 4.6 ± 0.13 3.1 ± 0.21 2.12 ± 0.11
Stomach 1.12 ± 0.11 1.28 ± 0.11 1.9 ± 0.01 1.33 ± 0.01 1.43 ± 0.01 2.1 ± 0.02 1.8 ± 0.02 1.12 ± 0.06
Lungs 1.23 ± 0.12 1.5 ± 0.13 1.48 ± 0.11 1.37 ± 0.02 2.1 ± 0.01 1.7 ± 0.11 1.2 ± 0.02 1.4 ± 0.02
Heart 2.1 ± 0.21 1.61 ± 0.01 1.1 ± 0.11 1.2 ± 0.12 1.8 ± 0.11 1.2 ± 0.01 1.6 ± 0.11 1.5 ± 0.02
Bone 2.2 ± 0.12 2.16 ± 0.21 2.13 ± 0.32 2.3 ± 0.13 1.94 ± 0.31 1.45 ± 0.03 0.9 ± 0.02 1.52 ± 0.13
Urine 9.23 ± 0.4 12.6 ± 0.4 21.3 ± 0.63 30.5 ± 0.83 10.5 ± 0.14 13.15 ± 1.14 28.86 ± 0.84 34.54 ± 0.15
T/NT 1.43 ± 0.01 3.0 ± 0.04 3.6 ± 0.11 2.0 ± 0.01 2.5 ± 0.01 4.4 ± 0.16 5.5 ± 0.12 3.70 ± 0.03
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bacterial cells (Figure 8).
Biodistribution of 99mTc-cefprozil
Table 1 shows the biodistribution of 99mTc-cefprozil in
important body organs and fluids. 99mTc-cefprozil was
removed from the circulation mainly through the
kidneys and urine (approximately 42.79% injected dose,
ID, at 4 h after injection of the tracer). The liver uptake
decreased markedly with time from 15.33% at 15 min to























Figure 8 In vitro binding of 99mTc-cefprozil to Staphylococcus aureus.with 99mTc-cefprozil showed a mean target-to-non-target
(T/NT) ratio equal to 5.5 ± 0.12 which is greater than that
of 99mTc-ciprofloxacin (T/NT = 3.8 ± 0.8) (Ibrahim et al.
2011). The accumulation of activity at the site of infection
was maximized at 2 h after intravenous injection then
slightly decreased with time until T/NT was equal to
3.70 ± 0.03 at 4 h post injection. During the first 2 h,
the radioactivity level in the blood was higher than that in
the inflammation-induced area. This means that the
images of 99mTc-cefprozil by gamma camera will be
affected by the blood pool images that arise from the3 4
n time, hours
o excess cefprozil
0 fold   cefprozil
0 fold   cefprozil
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Figure 9 T/NT of 99mTc-cefprozil complex in different inflammation models at different post injection times.
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obtain more specific images for 99mTc-cefprozil after
4 h (Figure 9).
Conclusion
99mTc-cefprozil was labeled easily using 50 μg SnCl2·2H2O
as a reducing agent at pH 4 and 30-min reaction time with
high labeling yield of 97.5% ± 0.8%. The 99mTc-cefprozil
complex was stable up to 6 h, which shows high stability
time in comparison to ciprofloxacin. Based on the data
obtained from the biodistribution of 99mTc-cefprozil, it can
be stated that there is a significant difference in the
percentage uptake of 99mTc-cefprozil in the muscle injected
with S. aureus and turpentine oil, which indicated that
99mTc-cefprozil is considered as a specific agent and
could distinguish between bacterial infection and sterile
inflammation. This result was supported by the data from
in vitro binding of 99mTc-cefprozil with bacteria.
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